|
|
Other links at Articles > Allergy and Clinical Immunology |
| 3. |
FDA Approvals: Alvesco and Tysabri
|
|
|
The FDA has approved ciclesonide inhalation aerosol (Alvesco) and a new indication for natalizumab intravenous infusion (Tysabri). Medscape Medical News
|
| 4. |
Non-Aluminum Adjuvant Boosts Immunogenicity of H5N1 Flu Vaccine
|
|
|
MF59, an oil-in-water emulsion adjuvant approved since 1997 by several European countries for use in seasonal influenza vaccines, increases the immunogenicity of an H5N1 avian influenza vaccine, according to a study reported in the March 1 issue of the Journal of Infectious Diseases. Reuters Health Information
|
| 5. |
Japan to Vaccinate Medical Workers Against Bird Flu
|
|
|
Japan plans to vaccinate 6,000 medical workers and quarantine officers with stockpiled bird flu vaccines to check their effectiveness and possible side effects, the health ministry said on Tuesday. Reuters Health Information
|
|
|